Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Mark Neumann. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Mark Neumann har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ITCI / Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Mark Neumann. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Mark Neumann som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-04-02 2025-04-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
D - Sale to Issuer -52.811 0 -100,00 132,00 -6.971.052
2025-03-10 2025-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -3.116 52.811 -5,57 131,24 -408.944 6.930.916
2025-03-10 2025-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7.345 55.927 15,12
2025-03-10 2025-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -5.572 48.582 -10,29 131,19 -730.991 6.373.473
2025-03-10 2025-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13.133 54.154 32,02
2025-03-04 2025-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -3.709 41.021 -8,29 128,20 -475.494 5.258.892
2025-03-04 2025-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 8.742 44.730 24,29
2025-02-04 2025-01-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes -4.729 35.988 -11,61 127,00 -600.583 4.570.476
2025-02-04 2025-01-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 11.017 40.717 37,09
2024-08-20 2024-08-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -18.714 29.700 -38,65 75,08 -1.405.047 2.229.876
2024-08-20 2024-08-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 18.714 48.414 63,01 36,89 690.359 1.785.992
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1.313 29.700 -4,23 66,86 -87.787 1.985.742
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1.729 31.013 -5,28 65,92 -113.976 2.044.377
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.303 32.742 -11,62 65,11 -280.168 2.131.832
2024-03-11 2024-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7.345 37.045 24,73
2024-03-11 2024-03-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.496 29.700 -13,15 66,95 -301.007 1.988.415
2024-03-11 2024-03-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -8.636 34.196 -20,16 66,37 -573.171 2.269.589
2024-03-08 2024-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13.132 42.832 44,22
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1.307 29.700 -4,22 71,18 -93.032 2.114.046
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -2.341 31.007 -7,02 70,70 -165.509 2.192.195
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.059 33.348 -10,85 69,56 -282.344 2.319.687
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -200 37.407 -0,53 68,03 -13.606 2.544.798
2024-02-27 2024-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7.907 37.607 26,62
2024-02-05 2024-02-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6.904 29.700 -18,86 67,49 -465.951 2.004.453
2024-02-05 2024-02-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.956 36.604 -11,92 66,67 -330.417 2.440.389
2024-02-05 2024-02-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 11.860 41.560 39,93
2023-11-08 2023-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -15.639 29.700 -34,49 55,02 -860.417 1.634.017
2023-11-08 2023-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -26.754 45.339 -37,11 55,98 -1.497.734 2.538.154
2023-11-08 2023-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 26.754 72.093 59,01 23,94 640.491 1.725.906
2023-08-09 2023-08-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -55.300 45.339 -54,95 58,79 -3.251.087 2.665.480
2023-08-09 2023-08-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 55.300 100.639 121,97 18,59 1.028.027 1.870.879
2023-03-30 2023-03-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -10.183 45.339 -18,34 54,01 -549.984 2.448.759
2023-03-30 2023-03-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -5.421 55.522 -8,90 54,86 -297.396 3.045.937
2023-03-13 2023-03-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -423 60.943 -0,69 44,05 -18.633 2.684.539
2023-03-13 2023-03-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -3.335 61.366 -5,15 45,10 -150.408 2.767.607
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7.344 64.701 12,80
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1.800 57.357 -3,04 42,74 -76.932 2.451.438
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6.750 59.157 -10,24 43,50 -293.625 2.573.330
2023-03-13 2023-03-09 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 16.708 65.907 33,96
2023-03-03 2023-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -7.241 49.199 -12,83 50,01 -362.122 2.460.442
2023-02-27 2023-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.046 56.440 -6,69 47,12 -190.648 2.659.453
2023-02-27 2023-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7.906 60.486 15,04
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -635 52.580 -1,19 48,93 -31.071 2.572.739
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -123 53.215 -0,23 47,32 -5.820 2.518.134
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -3.140 53.338 -5,56 46,61 -146.355 2.486.084
2023-02-22 2023-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11.139 56.478 24,57
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
M - Exercise -86.348 0 -100,00
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -14.885 45.339 -24,72 65,14 -969.609 2.953.382
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -53.987 60.224 -47,27 64,42 -3.477.843 3.879.630
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -17.476 114.211 -13,27 63,55 -1.110.600 7.258.109
2022-04-08 2022-04-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 86.348 131.687 190,45 12,73 1.099.210 1.676.376
2022-03-14 2022-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 22.034 22.034
2022-03-14 2022-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 17.916 17.916
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1.371 45.339 -2,94 51,33 -70.373 2.327.251
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -3.875 46.710 -7,66 52,03 -201.616 2.430.321
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -2.660 50.585 -5,00 52,94 -140.820 2.677.970
2022-02-25 2022-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -7.906 15.813 -33,33
2022-02-25 2022-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7.906 53.245 17,44
2022-02-23 2022-02-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.607 45.339 -9,22 54,84 -252.648 2.486.391
2022-02-23 2022-02-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6.532 49.946 -11,57 55,60 -363.179 2.776.998
2022-02-23 2022-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -11.139 11.139 -50,00
2022-02-23 2022-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11.139 56.478 24,57
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.252 45.339 -8,57 40,09 -170.463 1.817.641
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -13.935 49.591 -21,94 40,80 -568.548 2.023.313
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -2.761 63.526 -4,17 41,74 -115.244 2.651.575
2022-01-11 2022-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -20.948 0 -100,00
2022-01-11 2022-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20.948 66.287 46,20
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -500 45.339 -1,09 38,88 -19.440 1.762.780
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -1.958 45.839 -4,10 39,44 -77.224 1.807.890
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.288 47.797 -8,23 40,77 -174.822 1.948.684
2021-10-19 2021-10-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6.702 52.085 -11,40 41,49 -278.066 2.161.007
2021-10-19 2021-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13.448 0 -100,00
2021-10-19 2021-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13.448 58.787 29,66
2021-02-25 2021-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 23.719 23.719
2021-02-25 2021-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 18.714 18.714
2021-02-22 2021-02-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -600 45.339 -1,31 38,90 -23.340 1.763.687
2021-02-22 2021-02-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -4.584 45.939 -9,07 39,26 -179.968 1.803.565
2021-02-22 2021-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -11.139 22.278 -33,33
2021-02-22 2021-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11.139 50.523 28,28
2021-01-12 2021-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -9.684 39.384 -19,74 32,02 -310.082 1.261.076
2021-01-12 2021-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -20.948 20.948 -50,00
2021-01-12 2021-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20.948 49.068 74,50
2020-10-16 2020-10-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6.792 28.120 -19,45 26,80 -182.026 753.616
2020-10-16 2020-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13.448 13.448 -50,00
2020-10-16 2020-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13.448 34.912 62,65
2020-02-20 2020-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 33.417 33.417
2020-02-20 2020-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 26.754 26.754
2020-01-10 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -20.947 41.896 -33,33
2020-01-10 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
J - Other -6.157 21.464 -22,29 26,34 -162.175 565.362
2020-01-10 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20.947 27.621 313,86
2019-10-17 2019-10-16 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -6.774 6.674 -50,37 8,25 -55.886 55.060
2019-10-17 2019-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise -13.448 26.896 -33,33
2019-10-17 2019-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Common stock
M - Exercise 13.448 13.448
2019-01-10 2019-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 62.843 62.843
2019-01-10 2019-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 86.348 86.348
2018-10-17 2018-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 40.344 40.344
2018-10-17 2018-10-15 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 55.300 55.300
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)